JP2022506445A5 - - Google Patents
Info
- Publication number
- JP2022506445A5 JP2022506445A5 JP2021523833A JP2021523833A JP2022506445A5 JP 2022506445 A5 JP2022506445 A5 JP 2022506445A5 JP 2021523833 A JP2021523833 A JP 2021523833A JP 2021523833 A JP2021523833 A JP 2021523833A JP 2022506445 A5 JP2022506445 A5 JP 2022506445A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- groups
- alkyl
- independently
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862752414P | 2018-10-30 | 2018-10-30 | |
| US62/752,414 | 2018-10-30 | ||
| PCT/US2019/058268 WO2020092196A1 (en) | 2018-10-30 | 2019-10-28 | Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of il-12, il-23 and/or ifn-alpha |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022506445A JP2022506445A (ja) | 2022-01-17 |
| JP2022506445A5 true JP2022506445A5 (cg-RX-API-DMAC7.html) | 2022-11-07 |
| JP7489381B2 JP7489381B2 (ja) | 2024-05-23 |
Family
ID=68582450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021523833A Active JP7489381B2 (ja) | 2018-10-30 | 2019-10-28 | Il-12、il-23および/またはifnアルファの調節に関連する疾患を治療するためのアミド置換ヘテロ環化合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12240840B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3873892A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7489381B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102858043B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113227071B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019373203B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021007861A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3118094A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA202191142A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL282840B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021004562A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202104307VA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020092196A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021195360A1 (en) * | 2020-03-27 | 2021-09-30 | Landos Biopharma, Inc. | Plxdc2 ligands |
| KR20230004771A (ko) | 2020-04-28 | 2023-01-06 | 브리스톨-마이어스 스큅 컴퍼니 | Il-12, il-23 및/또는 ifn알파 조정제로서의 치환된 n-(메틸-d3)피리다진-3-카르복스아미드 또는 n-(메틸-d3)-니코틴아미드 화합물 |
| KR102698413B1 (ko) | 2020-05-05 | 2024-08-26 | 뉴베일런트, 아이엔씨. | 헤테로방향족 거대환식 에터 화학치료제 |
| WO2021226208A2 (en) | 2020-05-05 | 2021-11-11 | Nuvalent, Inc. | Heteroaromatic macrocyclic ether chemotherapeutic agents |
| CN113773262B (zh) * | 2020-06-09 | 2024-08-09 | 江苏先声药业有限公司 | 哒嗪类化合物 |
| CN114057651B (zh) * | 2020-07-31 | 2025-05-27 | 正大天晴药业集团股份有限公司 | 含酰胺基的tyk2抑制剂化合物 |
| CN116547276A (zh) * | 2020-12-08 | 2023-08-04 | 正大天晴药业集团股份有限公司 | 含酰胺基和杂环烷基的tyk2抑制剂化合物 |
| CN122520625A (zh) | 2020-12-22 | 2026-08-07 | 益方生物科技(上海)股份有限公司 | 杂芳基化合物及其制备方法和用途 |
| CN114907326B (zh) * | 2021-02-06 | 2025-02-18 | 正大天晴药业集团股份有限公司 | 含酰胺基和联环的tyk2抑制剂化合物 |
| TWI925948B (zh) * | 2021-02-06 | 2026-05-21 | 大陸商正大天晴藥業集團股份有限公司 | 含聯環的tyk2抑制劑化合物、藥物組合物及其用途 |
| EP4308556A4 (en) * | 2021-03-16 | 2025-02-19 | Anrui Biomedical Technology (Guangzhou) Co., Ltd. | Amino heteroaryl compounds and compositions |
| KR20240007242A (ko) * | 2021-05-14 | 2024-01-16 | 브리스톨-마이어스 스큅 컴퍼니 | 치환된 헤테로시클릭 화합물 |
| US20240317718A1 (en) * | 2021-05-14 | 2024-09-26 | Bristol-Myers Squibb Company | Substituted heterocyclic compounds |
| KR20240008338A (ko) * | 2021-05-14 | 2024-01-18 | 브리스톨-마이어스 스큅 컴퍼니 | 치환된 헤테로시클릭 화합물 |
| WO2022253335A1 (zh) * | 2021-06-02 | 2022-12-08 | 南京明德新药研发有限公司 | 含磺酰基的芳基类化合物及其应用 |
| WO2022253333A1 (zh) * | 2021-06-02 | 2022-12-08 | 南京明德新药研发有限公司 | 酰胺类化合物及其应用 |
| CN115466289B (zh) * | 2021-06-11 | 2026-07-03 | 爱科诺生物医药(苏州)有限公司 | 具有tyk2抑制活性的化合物,包含其的药物组合物,及其应用 |
| CA3223641A1 (en) * | 2021-06-22 | 2022-12-29 | Wenyuan Qian | Sulfoximine compound and use thereof |
| CN117794911A (zh) * | 2021-07-15 | 2024-03-29 | 南京明德新药研发有限公司 | 含硫/磷的芳基类化合物及其应用 |
| WO2023027948A1 (en) * | 2021-08-21 | 2023-03-02 | Relay Therapeutics, Inc. | Jak2 inhibitors and methods of use thereof |
| TW202320768A (zh) | 2021-10-01 | 2023-06-01 | 美商努法倫特公司 | 雜芳族大環醚化合物之固體形式、醫藥組成物及製備 |
| KR20240111312A (ko) | 2021-10-25 | 2024-07-16 | 카이메라 쎄라퓨틱스 인코포레이티드 | Tyk2 분해제 및 이의 용도 |
| TW202339749A (zh) | 2021-12-16 | 2023-10-16 | 大陸商凌科藥業有限公司 | Tyk2抑制劑及其組合物和方法 |
| CN116283928A (zh) * | 2021-12-20 | 2023-06-23 | 艾立康药业股份有限公司 | 一种哒嗪类化合物、其制备方法和应用 |
| WO2023213308A1 (zh) * | 2022-05-05 | 2023-11-09 | 苏州隆博泰药业有限公司 | 酰胺取代的杂环化合物及其医药用途 |
| CN117263913A (zh) | 2022-06-20 | 2023-12-22 | 益方生物科技(上海)股份有限公司 | 杂芳基化合物、固体形式、制备方法及其用途 |
| JP2025523848A (ja) * | 2022-07-14 | 2025-07-25 | バイオジェン・エムエイ・インコーポレイテッド | チロシンキナーゼ2阻害剤及びその使用 |
| WO2024044486A1 (en) * | 2022-08-22 | 2024-02-29 | Ajax Therapeutics, Inc. | Jak2 inhibitor compounds |
| CN120152968A (zh) * | 2022-11-08 | 2025-06-13 | 百时美施贵宝公司 | 取代的杂环化合物 |
| JP2025539787A (ja) * | 2022-11-16 | 2025-12-09 | ヴァーンウィ セラピューティクス,インコーポレイテッド | Tyk2阻害剤 |
| AU2023412260A1 (en) * | 2022-12-22 | 2025-05-29 | Usynova Pharmaceuticals Ltd. | Salt form and crystal form of pyridine multi-substituted compound and preparation method therefor |
| WO2024174229A1 (en) * | 2023-02-24 | 2024-08-29 | Anrui Biomedical Technology (Guangzhou) Co., Ltd. | Covalent binding compounds and compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2922841B8 (en) * | 2012-11-08 | 2017-08-02 | Bristol-Myers Squibb Company | Alkyl-amide-substituted pyridyl compounds useful as modulators of il-12, il-23 and/or ifn alpha responses |
| HRP20220766T1 (hr) * | 2012-11-08 | 2022-09-16 | Bristol-Myers Squibb Company | Amidom-supstituirani heterociklički spojevi korisni kao modulatori il-12, il-23 i/ili ifn alfa odgovora |
| AR094537A1 (es) * | 2013-11-07 | 2015-08-12 | Bristol Myers Squibb Co | COMPUESTOS DE PIRIDILO SUSTITUIDOS CON ALQUILAMIDA ÚTILES COMO MODULADORES DE LAS RESPUESTAS DE IL-12, IL-23 Y/O IFNa |
| JP7485609B2 (ja) * | 2018-03-22 | 2024-05-16 | ブリストル-マイヤーズ スクイブ カンパニー | IL-12、IL-23および/またはIFNα応答のモジュレーターとして有用なピリジン含有ヘテロ環式化合物 |
| PE20250262A1 (es) * | 2021-05-14 | 2025-01-29 | Bristol Myers Squibb Co | Compuestos heterociclicos sustituidos |
-
2019
- 2019-10-28 KR KR1020217016043A patent/KR102858043B1/ko active Active
- 2019-10-28 US US17/289,269 patent/US12240840B2/en active Active
- 2019-10-28 SG SG11202104307VA patent/SG11202104307VA/en unknown
- 2019-10-28 IL IL282840A patent/IL282840B2/en unknown
- 2019-10-28 AU AU2019373203A patent/AU2019373203B2/en not_active Ceased
- 2019-10-28 EA EA202191142A patent/EA202191142A1/ru unknown
- 2019-10-28 BR BR112021007861-4A patent/BR112021007861A2/pt unknown
- 2019-10-28 CN CN201980085746.8A patent/CN113227071B/zh active Active
- 2019-10-28 EP EP19805033.8A patent/EP3873892A1/en active Pending
- 2019-10-28 MX MX2021004562A patent/MX2021004562A/es unknown
- 2019-10-28 WO PCT/US2019/058268 patent/WO2020092196A1/en not_active Ceased
- 2019-10-28 JP JP2021523833A patent/JP7489381B2/ja active Active
- 2019-10-28 CA CA3118094A patent/CA3118094A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2361868C2 (ru) | Новые производные тиазола | |
| US9763957B2 (en) | Autotaxin inhibitors | |
| RU2374230C2 (ru) | Фенильные производные в качестве ppar агонистов | |
| JP2018503661A5 (cg-RX-API-DMAC7.html) | ||
| JP2004502670A5 (cg-RX-API-DMAC7.html) | ||
| RU2010115574A (ru) | Замещенные амиды, фармацевтическая композиция на их основе, способ лечения заболевания, чувствительного к btk, способ повышения чувствительности раковых клеток к химиотерапии, способ уменьшения ошибок при приеме лекарства и улучшения соблюдения схемы лечения, способ ингибирования гидролиза атф, способ определения присутствия btk в образце и способ ингибирования активности в-клеток | |
| JP2007519695A5 (cg-RX-API-DMAC7.html) | ||
| JP2017214387A5 (cg-RX-API-DMAC7.html) | ||
| JP2010513283A (ja) | 新規なオキサジアゾール化合物 | |
| JP2017193592A5 (cg-RX-API-DMAC7.html) | ||
| JP2005535586A5 (cg-RX-API-DMAC7.html) | ||
| RU2010146384A (ru) | Пирролидиноновые активаторы глюкокиназы | |
| JP2007509130A5 (cg-RX-API-DMAC7.html) | ||
| JP2008501673A5 (cg-RX-API-DMAC7.html) | ||
| RU2011108932A (ru) | Карбазольные соединения и терапевтические применения соединений | |
| RU2015111133A (ru) | Ингибиторы тирозинкиназы брутона | |
| RU2011116232A (ru) | Пиразолопиридиновые производные как ингибиторы надфн-оксидазы | |
| JP2018502906A5 (cg-RX-API-DMAC7.html) | ||
| RU2015132105A (ru) | Азоловые производные бензола | |
| RU2016111522A (ru) | Фармацевтические соединения | |
| JP2013529206A5 (cg-RX-API-DMAC7.html) | ||
| HRP20190943T1 (hr) | Derivat 2-acilaminotiazola za uporabu u prevenciji ili liječenju bolesti mjehura/mokraćnog sustava | |
| JP2024518556A5 (cg-RX-API-DMAC7.html) | ||
| HRP20200606T1 (hr) | Derivati fenila kao agonisti kanabinoidnog receptora 2 | |
| JP2007211009A5 (cg-RX-API-DMAC7.html) |